SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-121408
Filing Date
2020-11-04
Accepted
2020-11-04 17:12:08
Documents
16
Period of Report
2020-11-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2035018d1_8k.htm   iXBRL 8-K 37107
2 EXHIBIT 99.1 tm2035018d1_ex99-1.htm EX-99.1 68360
3 EXHIBIT 99.2 tm2035018d1_ex99-2.htm EX-99.2 18753
7 GRAPHIC tm2035018d1_ex99-1img001.jpg GRAPHIC 14512
8 GRAPHIC tm2035018d1_ex99-2img001.jpg GRAPHIC 4054
  Complete submission text file 0001104659-20-121408.txt   347121

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ptgx-20201104.xsd EX-101.SCH 3207
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptgx-20201104_lab.xml EX-101.LAB 34591
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptgx-20201104_pre.xml EX-101.PRE 22724
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2035018d1_8k_htm.xml XML 3858
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37852 | Film No.: 201287546
SIC: 2834 Pharmaceutical Preparations